Pathology and Lab Medicine - Global Oncology Academy

Episodes 1-11 of 11

- Kevin J. Harrington, MBBS, PhD
  Peer
- Barbara Burtness, MD
  Peer
- Ari Rosenberg, MD
  Peer
2
CME/CE
Innovations in the Treatment of Locally Advanced Squamous Cell Carcinoma of Head and Neck: Enhancing Antitumor Activity Through Inhibitor of Apoptosis Protein Antagonism
Innovations in the Treatment of Locally Advanced Squamous Cell Carcinoma of Head and Neck: Enhancing Antitumor Activity Through Inhibitor of Apoptosis Protein Antagonism
0.25 credits
Innovations in the Treatment of Locally Advanced Squamous Cell Carcinoma of Hea…
0.25 credits
- Nichole Tanner, MD, MS, FCCP
  Peer
- Eric Edell, MD, FCCP
  Peer
- Septimiu Murgu, MD, FCCP
  Peer
0
CME/CE
Lung Cancer Screening & What to Do When a Nodule Is Detected
Lung Cancer Screening & What to Do When a Nodule Is Detected
0.25 credits
Lung Cancer Screening & What to Do When a Nodule Is Detected
0.25 credits
- Paul Paik, MD
  Peer
- Catherine Shu, MD
  Peer
2
CME/CE
Evaluating Your Current Options in the Treatment of NSCLC with METex14 Skipping Mutations
Evaluating Your Current Options in the Treatment of NSCLC with METex14 Skipping Mutations
0.25 credits
Evaluating Your Current Options in the Treatment of NSCLC with METex14 Skipping…
0.25 credits
- Jyoti D. Patel, MD, FASCO
  Peer
1
CME/CE
Patient-Centered Discussions and Shared Decision-Making in the Management of NSCLC with METex14 Skipping Mutations
Patient-Centered Discussions and Shared Decision-Making in the Management of NSCLC with METex14 Skipping Mutations
0.25 credits
Patient-Centered Discussions and Shared Decision-Making in the Management of NS…
0.25 credits
- Janani Reisenauer, MD
  Peer
- Septimiu Murgu, MD, FCCP
  Peer
- Eric Edell, MD, FCCP
  Peer
0
CME/CE
Management Tools for Early-Stage Lung Cancer
Management Tools for Early-Stage Lung Cancer
0.25 credits
Management Tools for Early-Stage Lung Cancer
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Elena Elez, MD, PhD
  Peer
- Elizabeth Smyth, MD
  Peer
1
CME/CE
Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer
Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer
0.25 credits
Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer
0.25 credits
- Jacob Sands, MD
  Peer
- Sara A. Hurvitz, MD, FACP
  Peer
- Paolo Tarantino, MD
  Peer
4
Project Oncology®
Gaining Ground on HER2-Low Breast Cancer Priorities: Shared Decision-Making in Practice
Gaining Ground on HER2-Low Breast Cancer Priorities: Shared Decision-Making in Practice
Gaining Ground on HER2-Low Breast Cancer Priorities: Shared Decision-Making in …
- Jacob Sands, MD
  Peer
- Lori Pierce, MD, FASTRO, FASCO
  Peer
4
Project Oncology®
ASCO Investigates Disparities in Cancer Care: Representation in Oncology
ASCO Investigates Disparities in Cancer Care: Representation in Oncology
ASCO Investigates Disparities in Cancer Care: Representation in Oncology
- John J. Russell, MD
  Peer
- Meredith Wadman, BM, BCh, M.S.
  Peer
6
Book Club
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
- Matt Birnholz, MD
  Peer
11
Project Oncology®
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
- Ana Maria Rosario
  Peer
19
Clinician's Roundtable
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis

A Look Behind the Curtain: Exploring Lower-Risk MDS-RS & MDS/MPN-RS-T

Guillermo Garcia-Manero, MD

A Look Behind the Curtain: Exploring Lower-Risk MDS-RS & MDS/MPN-RS-T

Learn More

A Look Behind the Curtain: Exploring Lower-Risk MDS-RS & MDS/MPN-RS-T

UP NEXT...

NIVO and RELA versus NIVO in Previously Untreated Metastatic or Unresectable Melanoma: Additional Response Outcomes from RELATIVITY-047

CME

Guest
Jason Luke, MD